JESUS L PENABAD
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism HUDSON, FL NPI 1285637553
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism FL SANOFI-AVENTIS U.S. LLC All categories
General Payments — all program years on this page
$36,469.07
- Category: General Payments
- Program years: PY2018–2024
- Record count: 780
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,907.61 across 86 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,864.05 | 84 |
| Education | $43.56 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $277.34 | 6 |
| Novo Nordisk AS | $253.17 | 13 |
| Corcept Therapeutics | $204.50 | 10 |
| BETA BIONICS, INC. | $164.20 | 4 |
| Lilly USA, LLC | $146.93 | 11 |
| Bayer HealthCare Pharmaceuticals Inc. | $140.00 | 8 |
| Abbott Laboratories | $138.33 | 12 |
| Medtronic, Inc. | $109.89 | 1 |
| DEXCOM, INC. | $76.49 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $60.63 | 3 |
| Amgen Inc. | $53.13 | 3 |
| Nevro Corp. | $47.73 | 3 |
| PFIZER INC. | $41.33 | 2 |
| Xeris Pharmaceuticals, Inc. | $40.88 | 2 |
| Amneal Pharmaceuticals LLC | $38.82 | 2 |
| Neurocrine BioSciences, Inc. | $28.61 | 1 |
| Insulet Corporation | $23.34 | 1 |
| Renalytix AI, Inc. | $23.10 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.83 | 1 |
| Averitas Pharma Inc. | $19.36 | 1 |
By program year
Records — PY2024 (86)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.